ZTS: יחס הלוואות לטווח ארוך להון Zoetis Inc.

Zoetis Inc. (ZTS) global reach in veterinary medicine creates risks due to logistical disruptions and currency volatility, as confirmed by the market price on this chart, which reached 3.12. The business relies on partnerships with agritech startups and clinics to implement innovations. Stable revenue is secured by high markups on pharmaceuticals, despite the costs of new drug certification and R&D.

To minimize long-term risks, it is essential for investors to evaluate the ratio of liabilities with a maturity of over one year to equity, which determines the company's degree of financial autonomy. The current long-term debt-to-equity ratio for Zoetis Inc. (ZTS) stands at 3.12, confirming the stability of its financing structure amid expansion in the critical veterinary medicine sector and the pursuit of global food security.